AccScience Publishing / JCBP / Volume 1 / Issue 2 / DOI: 10.36922/jcbp.1001
Submit to JCBP
Cite this article
56
Download
1644
Views
Journal Browser
Volume | Year
Issue
Search
Forthcoming Issue
Current Issue
View All
News and Announcements
View All
BRIEF REPORT

The prevalence of skin disorders in patients with schizophrenia

Narang Tarun1 ,  Natarajan Varadharajan2 ,  Seema Rani2 ,  Hitaishi Mehta1 ,  Sanjana Kathiravan2 ,  Shubh Mohan Singh2*
Show Less
1 Department of Dermatology, Leprology and Venereology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
2 Department of Psychiatry, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
JCBP 2023, 1(2), 1001 https://doi.org/10.36922/jcbp.1001
Submitted: 26 May 2023 | Accepted: 10 July 2023 | Published: 1 August 2023
© 2023 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution 4.0 International License ( https://creativecommons.org/licenses/by/4.0/ )
Download PDF
Cite
XML
Abstract

There is ample evidence suggesting the presence of various multisystemic comorbidities in patients with schizophrenia. However, data on dermatological comorbidities in these patients are scarce. The present study aimed to analyze the profile of cutaneous conditions in patients with schizophrenia and contribute to the existing evidence in this area. A total of 102 consecutive adult patients with schizophrenia, who were attending the follow-up service at the outpatient clinic of the Department of Psychiatry in a tertiary hospital in North India, were evaluated by a dermatologist for the presence of any skin disorder. Dermatological findings were noted in 70% of patients and 38% had multiple skin conditions. Infections were the most prevalent diagnosis, with fungal infections being commonly observed. Other common dermatoses included nevi, age-related cutaneous changes, dyschromia, and drug-induced acne. The present study concluded that there is a high prevalence of dermatological diseases in patients with schizophrenia. Caregivers and psychiatrists managing these patients should familiarize themselves with these conditions, and dermatology consultation should be sought for prompt diagnosis and management.

Keywords
Schizophrenia
Psychosomatics
Dermatoses
Psychodermatology
Funding
None.
Conflict of interest
The authors declare that they have no competing interests.
References
  1. Van Haren NE, Cahn W, Hulshoff Pol HE, et al., 2008, Schizophrenia as a progressive brain disease. Eur Psychiatry, 23: 245–254. https://doi.org/10.1016/j.eurpsy.2007.10.013

 

  1. Ansel JC, Kaynard AH, Armstrong CA, et al., 1996, Skin-nervous system interactions. J Invest Dermatol, 106: 198–204. https://doi.org/10.1111/1523-1747.ep12330326

 

  1. Mahadik SP, Mukherjee S, Laev H, et al., 1991, Abnormal growth of skin fibroblasts from schizophrenic patients. Psychiatry Res, 37: 309–320. https://doi.org/10.1016/0165-1781(91)90066-x

 

  1. Müller N, Schwarz MJ, 2010, Immune system and schizophrenia. Curr Immunol Rev, 6: 213–220. https://doi.org/10.2174/157339510791823673

 

  1. Molina-Ruiz AM, Pulpillo A, Molina-Ruiz RM, et al., 2016, Chlorpromazine-induced severe skin pigmentation and corneal opacities in a patient with schizophrenia. Int J Dermatol, 55: 909–912. https://doi.org/10.1111/ijd.13085

 

  1. Singh LK, Sahu M, Praharaj SK, 2015, Olanzapine-induced reversible pellagroid skin lesion. Curr Drug Saf, 10: 251–253. https://doi.org/10.2174/1574886310666150616143621

 

  1. Singh SM, Surendran I, Jain S, et al., 2019, The prevalence of non-communicable disease risk factors in community-living patients with psychiatric disorders: A study from North India. Asian J Psychiatry, 41: 23–27. https://doi.org/10.1016/j.ajp.2019.03.004

 

  1. Mookhoek E, Van De Kerkhof PC, Hovens JE, et al., 2010, Skin disorders in chronic psychiatric illness. J Eur Acad Dermatol Venereol, 24: 1151–1156. https://doi.org/10.1111/j.1468-3083.2010.03609.x

 

  1. George A, Girisha BS, Rao S, 2018, A perspective study of cutaneous manifestations in primary psychiatric disorders in a tertiary care hospital. Indian J Psychiatry, 60: 213–226. https://doi.org/10.4103/psychiatry.IndianJPsychiatry_156_18

 

  1. Kuruvila M, Gahalaut P, Zacharia A, 2004, A study of skin disorders in patients with primary psychiatric conditions. Indian J Dermatol Venereol Leprol, 70: 292–295.

 

  1. Moftah NH, Kamel AM, Attia HM, et al., 2013, Skin diseases in patients with primary psychiatric conditions: A hospital based study. J Epidemiol Glob Health, 3: 131–138. https://doi.org/10.1016/j.jegh.2013.03.005

 

  1. Wu B, Wu B, Lee S, et al., 2014, Prevalence and associated factors of comorbid skin diseases in patients with schizophrenia: A clinical survey and national health database study. Gen Hosp Psychiatry, 36: 415–421. https://doi.org/10.1016/j.genhosppsych.2014.02.008

 

  1. Luepker R, Evans A, McKeigue P, et al., 2004, Cardiovascular Survey Methods. Geneva: World Health Organization.

 

  1. Busner J, Targum SD, 2007, The clinical global impressions scale: Applying a research tool in clinical practice. Psychiatry (Edgmont), 4: 28–37.

 

  1. Anon, n.d, Hypertension (High Blood Pressure). National Health Portal of India. Available from: https://www.nhp. gov.in/disease/cardio-vascular/hypertension-high-blood-pressure [Last accessed on 2018 Nov 16].

 

  1. Mattoo SK, Singh SM, 2010, Prevalence of metabolic syndrome in psychiatric inpatients in a tertiary care centre in North India. Indian J Med Res, 131: 46–52.

 

  1. Jain S, Barambhe MS, Jain J, et al., 2016, Prevalence of skin diseases in rural central India: A community-based, cross-sectional, observational study. J Mahatma Gandhi Inst Med Sci, 21: 111–115. https://doi.org/10.4103/0971-9903.189537

 

  1. Chatterjee N, Chattopadhyay C, Sengupta N, et al., 2014, An observational study of cutaneous manifestations in diabetes mellitus in a tertiary care hospital of Eastern India. Indian J Endocrinol Metab, 18: 217–220. https://doi.org/10.4103/2230-8210.129115

 

  1. McPhie ML, Bridgman AC, Kirchhof MG, 2020, A review of skin disease in schizophrenia. Dermatology, 237: 1–14. https://doi.org/10.1159/000508868

 

  1. Bliss SA, Warnock JK, 2013, Psychiatric medications: Adverse cutaneous drug reactions. Clin Dermatol, 31: 101–109. https://doi.org/10.1016/j.clindermatol.2011.11.014

 

  1. Higgins JC, Maher MH, Douglas MS, 2015, Diagnosing common benign skin tumors. Am Fam Physician, 92: 601–607.

 

  1. Horváth S, Mirnics K, 2014, Immune system disturbances in schizophrenia. Biol Psychiatry, 75: 316–323. https://doi.org/10.1016/j.biopsych.2013.06.010

 

  1. Seeman MV, 2011, Antipsychotics and physical attractiveness. Clin Schizophr Relat Psychoses, 5: 142–146. https://doi.org/10.3371/CSRP.5.3.4

 

  1. Nayak K, Gopinath H, Kini H, et al., 2015, Unmasking diogenes syndrome. Indian J Dermatol, 60: 287–289. https://doi.org/10.4103/0019-5154.156385
Share
Back to top
Journal of Clinical and Basic Psychosomatics, Electronic ISSN: 2972-4414 Published by AccScience Publishing
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here
Accept